Portfolio Company · Operating Co.
Luminopia
a portfolio company of
US Venture Partners
Status on record: Current
PE Firm Index

Who owns Luminopia?

Luminopia is listed as a current portfolio company of US Venture Partners on US Venture Partners' own portfolio page.

From the company's website

Luminopia is the first FDA-cleared binocular therapy for amblyopia.

Source: luminopia.com, read November 2026

Company Snapshot

Luminopia is a Healthcare company. Its owner on record, US Venture Partners, is a firm. US Venture Partners lists 144 companies in the index, 9 of them in Healthcare.

Parent PE firmUS Venture Partners
Ownership statusCurrent
WebsiteVisit ↗

About the owner

Questions about Luminopia

Who owns Luminopia?

Luminopia is listed as a current portfolio company of US Venture Partners on US Venture Partners' own portfolio page.

What sector is Luminopia in?

Luminopia is in Healthcare. Classified from the company's own description.

What else does US Venture Partners own in Healthcare?

US Venture Partners lists 8 other Healthcare companies in the index, including AImbient, Cagent Vascular, Carlsmed, Carrot and HighLife Medical.

What is Luminopia's website?

Luminopia's website is https://www.luminopia.com/.

Sources

This profile is based on publicly available information and may be incomplete or outdated. PE Firm Index is not affiliated with Luminopia and does not provide investment advice.

Other portfolio companies of US Venture Partners

6 of 143 shown

See the full US Venture Partners portfolio.

Other Healthcare companies held by US Venture Partners

Other Healthcare portfolio companies

Browse PE-backed companies.